Skip to main content
Log in

Anticoagulant ADR-related hospitalisations: costs examined

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Programme de Médicalisation des Systèmes d'Information

  2. Anticoagulant-related hospital admissions (public & private) were extracted from the PMSI database using two International Classification of Diseases, 10th revision (ICD-10) codes: "T45.5 - Poisoning by anticoagulants' and 'Y44.2 - Anticoagulants' adverse effect in therapeutic use'.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticoagulant ADR-related hospitalisations: costs examined. PharmacoEcon Outcomes News 710, 8 (2014). https://doi.org/10.1007/s40274-014-1481-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1481-z

Navigation